MEND syndrome: a case report with scanning electron microscopy findings of the collodion membrane
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Acta dermato-venereologica. - 96, 7 (2017) , 110 - 111, ISSN: 1651-2057
- Klassifikation
-
Medizin, Gesundheit
- Ereignis
-
Veröffentlichung
- (wo)
-
Freiburg
- (wer)
-
Universität
- (wann)
-
2019
- Urheber
- DOI
-
10.2340/00015555-2477
- URN
-
urn:nbn:de:bsz:25-freidok-1423374
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Almeida, Hiram Larangeira de
- Has, Cristina
- Rampon, G.
- Isaacsson, H.
- de Castro, L. A.
- Universität
Entstanden
- 2019
Ähnliche Objekte (12)
Dupilumab bessert kongenitale Ichthyose : = Dupilumab improves congenital ichthyosis
Dupilumab improves congenital ichthyosis
Advances in understanding the molecular basis of skin fragility
Strategy for the optimization of read-through therapy for junctional epidermolysis bullosa with COL17A1 nonsense mutation
Ausgewählte Genodermatosen – Stand der Dinge und Zukunftsaussichten
Secukinumab for the treatment of SAM syndrome associated with desmoglein‐1 deficiency
Update on genetic conditions affecting the skin and the kidneys
Molecular therapeutics in development for Epidermolysis bullosa: update 2020
Selected genodermatoses – Status quo and future prospects
Treatment of epidermolysis bullosa and future directions: a review
Homozygous nonsense mutation and additional deletion of an amino acid in BPAG1e causing mild localized Epidermolysis Bullosa simplex
Dupilumab improves itch and blistering in different subtypes of epidermolysis bullosa
Dupilumab bessert kongenitale Ichthyose : = Dupilumab improves congenital ichthyosis
Dupilumab improves congenital ichthyosis
Advances in understanding the molecular basis of skin fragility
Strategy for the optimization of read-through therapy for junctional epidermolysis bullosa with COL17A1 nonsense mutation
Ausgewählte Genodermatosen – Stand der Dinge und Zukunftsaussichten
Secukinumab for the treatment of SAM syndrome associated with desmoglein‐1 deficiency
Update on genetic conditions affecting the skin and the kidneys
Molecular therapeutics in development for Epidermolysis bullosa: update 2020
Selected genodermatoses – Status quo and future prospects
Treatment of epidermolysis bullosa and future directions: a review
Homozygous nonsense mutation and additional deletion of an amino acid in BPAG1e causing mild localized Epidermolysis Bullosa simplex
Dupilumab improves itch and blistering in different subtypes of epidermolysis bullosa
Dupilumab bessert kongenitale Ichthyose : = Dupilumab improves congenital ichthyosis
Dupilumab improves congenital ichthyosis
Advances in understanding the molecular basis of skin fragility
Strategy for the optimization of read-through therapy for junctional epidermolysis bullosa with COL17A1 nonsense mutation
Ausgewählte Genodermatosen – Stand der Dinge und Zukunftsaussichten
Secukinumab for the treatment of SAM syndrome associated with desmoglein‐1 deficiency
Update on genetic conditions affecting the skin and the kidneys
Molecular therapeutics in development for Epidermolysis bullosa: update 2020
Selected genodermatoses – Status quo and future prospects
Treatment of epidermolysis bullosa and future directions: a review
Homozygous nonsense mutation and additional deletion of an amino acid in BPAG1e causing mild localized Epidermolysis Bullosa simplex